IRIS
SOTA, JURGEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.785
EU - Europa 2.694
AS - Asia 433
SA - Sud America 14
AF - Africa 13
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.942
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.780
GB - Regno Unito 1.027
IE - Irlanda 522
IT - Italia 362
SE - Svezia 253
CN - Cina 227
UA - Ucraina 161
FR - Francia 124
DE - Germania 75
SG - Singapore 57
FI - Finlandia 56
VN - Vietnam 49
TR - Turchia 35
RU - Federazione Russa 28
BE - Belgio 23
CZ - Repubblica Ceca 18
PK - Pakistan 18
IN - India 15
ES - Italia 12
PL - Polonia 10
IR - Iran 9
EG - Egitto 7
BR - Brasile 6
HK - Hong Kong 5
NL - Olanda 5
AR - Argentina 3
BD - Bangladesh 3
CA - Canada 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
AM - Armenia 2
AU - Australia 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
MK - Macedonia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
PA - Panama 1
SA - Arabia Saudita 1
TH - Thailandia 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 5.942
Salva come PNG Salva come JPEG
Città #
Southend 965
Dublin 512
Fairfield 404
Ashburn 237
Woodbridge 227
Chandler 178
Menlo Park 176
Houston 160
Wilmington 152
Ann Arbor 150
Siena 142
Cambridge 138
Seattle 138
Jacksonville 132
Princeton 85
New York 73
Dearborn 60
Dong Ket 49
Beijing 47
Helsinki 44
San Mateo 42
Nanjing 41
Singapore 28
Boardman 26
San Diego 25
Moscow 23
Izmir 22
Brussels 21
Nanchang 16
Shanghai 15
Rome 14
Guangzhou 12
Hebei 12
Milan 12
Jiaxing 11
Shenyang 11
Florence 10
Jinan 10
Kunming 10
Olomouc 10
Kraków 9
Washington 9
Lahore 8
Málaga 8
Norwalk 8
Brno 7
Cagliari 7
Changsha 7
London 7
Redwood City 7
San Francisco 7
Taizhou 7
Bergamo 6
Catania 6
Tappahannock 6
Cardiff 5
Duncan 5
Istanbul 5
Munich 5
Padula 5
Sacramento 5
Tianjin 5
Uzzano 5
Zanjan 5
Edinburgh 4
Islamabad 4
Jhelum 4
Lancaster 4
Lappeenranta 4
Livorno 4
Nottingham 4
São Paulo 4
Augusta 3
Cecina 3
Changchun 3
Cipolletti 3
Dhaka 3
Frankfurt am Main 3
Hefei 3
Lima 3
Lisbon 3
Los Angeles 3
Pignone 3
Xian 3
Acton 2
Addis Ababa 2
Al Mansurah 2
Alexandria 2
Amsterdam 2
Bangalore 2
Cairo 2
Castelforte 2
Chicago 2
Falkenstein 2
Fiesole 2
Fremont 2
Huzhou 2
Kathmandu 2
Kocaeli 2
Lastra a Signa 2
Totale 4.694
Salva come PNG Salva come JPEG
Nome #
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 259
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 249
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 240
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 225
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 200
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 193
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 193
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 189
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 188
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 180
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 177
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 171
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 168
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 167
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 165
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 160
IL-6 blockade in the management of non-infectious uveitis 149
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 149
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 142
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 131
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 129
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 128
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 126
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 116
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 110
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 104
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 92
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 86
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 84
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema 77
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 75
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 74
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases 70
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 67
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 67
Efficacy and safety of abatacept in a patient with rheumatoid arthritis and concomitant Staphylococcus aureus osteomyelitis 65
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 65
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 63
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 63
Musculoskeletal manifestations in hereditary periodic fever syndromes 62
Impact of HLA-B51 on uveitis and retinal vasculitis: data from the AIDA International Network Registries on ocular inflammatory disorders 60
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome 57
The current status of biological treatment for uveitis 56
New potential weapons for refractory scleritis in the era of targeted therapy 56
Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 44
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 41
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 38
Development and implementation of the AIDA International Registry for patients with Behçet's disease 38
Comparing biologic options for the management of Behcet's disease-related uveitis 37
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 37
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 35
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 35
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 34
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 31
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 26
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 11
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 10
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 9
Power and spectral Doppler ultrasound in suspected active sacroiliitis: A comparison with magnetic resonance imaging as gold standard 8
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis 8
Therapeutic approach to central nervous system involvement of Behçet's disease 8
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 8
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 8
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 7
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: Observational study from the International AIDA Registry 7
Development and Implementation of the AIDA International Registry for Patients With Still's Disease 7
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study 7
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA network registries 6
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry 6
Autoinflammatory diseases and the kidney 6
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry 6
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network 6
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 5
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 5
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 5
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 5
Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: A narrative review 4
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 4
Off-label use of canakinumab in pediatric rheumatology and rare diseases 4
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 3
Polidistrectual videocapillaroscopic evaluation in a patient with prolidase deficiency 3
Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study 3
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry 3
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 3
The Role of Biologic Agents in the Management of Pediatric-Onset Noninfectious Posterior Scleritis 3
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 2
The diagnostic role of pathergy test in patients with Behçet’s disease from the Western Europe 2
The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still’s disease. A systematic review and meta-analysis of observational studies 2
Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study 2
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome—Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network 2
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome 2
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome 2
Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review 2
Effectiveness of SB5, an Adalimumab Biosimilar, in Patients With Noninfectious Uveitis: A Real-Life Monocentric Experience 2
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases 2
Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry 2
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis 2
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 2
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry 2
The treatment of adult-onset Still’s disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of the literature 2
Totale 6.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.120 113 48 48 141 60 166 114 133 104 95 41 57
2020/20211.229 127 96 54 75 98 197 63 167 74 116 43 119
2021/2022822 72 112 64 55 45 9 36 32 47 78 104 168
2022/2023804 57 71 132 94 57 153 28 63 72 12 37 28
2023/20241.062 39 24 91 56 32 298 302 55 12 18 48 87
2024/2025174 174 0 0 0 0 0 0 0 0 0 0 0
Totale 6.251